Is it the time to implement the routine use of distress thermometer among Egyptian patients with newly diagnosed cancer?

• Main Authors: Nashwa Abd El-Aziz, Salah Khallaf, Waleed Abozaid, Ghada Elgohary, Ola Abd El-Fattah, Mai Alhawari, Safaa Khaled, Azza AbdelHaffez, Ehab Kamel, Sherif Mohamed
• Format: Article
• Language: English
• Published: BMC 2020-10-01
• Series: BMC Cancer
• Subjects: Cancer; Distress thermometer; Egypt; New; Screening
• Online Access: http://link.springer.com/article/10.1186/s12885-020-07451-7

Abstract Background The distress thermometer (DT) is an effective tool for identifying distress among cancer patients worldwide. However, DT has not been studied in Egyptian patients. We aimed to study the prevalence of distress among Egyptian patients with different types of cancers using DT. Methods A total of 550 patients with newly diagnosed hematological and solid cancers who were followed up at 3 Oncology Centers in Egypt were enrolled. They completed a sociodemographic and clinical status questionnaire, the DT and the Problem List (PL) scale. Results At a DT cut-off score of ≥4, 46% of patients had significant distress, which was related to the tumor site and stage. The most frequent problems reported were treatment decision (64.4%), worry (47%), and fears (44.5%). In univariate logistic regression analysis, participants who had significant distress described 23 out of 36 problems in the practical, family, emotional, and physical areas. After adjustment to sociodemographic and clinical characteristics, multivariable analysis confirmed that insurance, depression, fear, sadness, worry, loss of interest in usual activity, and sleep were independent factors associated with significant distress in cancer patients. Conclusions Almost half of Egyptian patients newly diagnosed with cancer reported significant distress. Those who had significant distress described extra problems in the practical, family, emotional, and physical areas. We recommend the routine use of DT for screening Egyptian patients with cancer, as well as the involvement of the psycho-oncology and social services, at the time of their initial diagnosis.